asthma

News

FDA to review Sanofi's Dupixent in asthma

The FDA is to review Sanofi/Regeneron's Dupixent as a treatment for asthma, a new use that could more than double its sales following its previous approval for eczema.

News

Rumours of $1.65bn GSK bid for respiratory partners Vectura

GlaxoSmithKline could be poised to acquire its respiratory partner, UK biotech Vectura, for $1.65bn.

News

AZ's asthma drug Fasenra approved in EU

A further 3,400 children are eligible for treatment with Orkambi

News

GSK's Nucala gains US use in rare autoimmune disease

IL-5 drug approved in EGPA

Events

Partner Content

Asthma & COPD 2018

Asthma

News

FDA approves AstraZeneca's asthma injection

AZ taking on rivals from GSK and Teva.

FDA to review Sanofi's Dupixent in asthma

Rumours of $1.65bn GSK bid for respiratory partners Vectura

AZ's asthma drug Fasenra approved in EU

GSK's Nucala gains US use in rare autoimmune disease

Asthma & COPD 2018

FDA approves AstraZeneca's asthma injection

Lilly bags FDA okay for Wegovy pill rival orforglipron

Using AI-driven synthetic personas to take your insights fur...

asthma

Editor's Picks